Lymphokine-activated killer lymphocytes: extramural clinical trials
Sniecinski, I.J.
Immunology Series 48: 59-77
1989
ISSN/ISBN: 0092-6019 PMID: 2488326 Document Number: 337023
Document emailed within 1 workday
Related Documents
Lamers, H.J.; Gratama, J.W.; van Putten, W.L.; Stoter, G.; Bolhuis, R.L. 1991: Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes Cancer Research 51(9): 2324-2328Blacklock, J.B.; Grimm, E.A. 1989: Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system Immunology Series 48: 93-99
Silver, R.M. 1990: Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients Clinical and Experimental Rheumatology 8(5): 481-486
Merluzzi, V.J.; Trail, P.A.; Last-Barney, K. 1986: Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow Journal of Immunology 137(8): 2425-2427
Jíra, M.; Malkovský, M.; Denman, A.M.; Loveland, B.; Lyons, D.; Dalgleish, A.G.; Webster, A.D. 1987: Lymphokine-activated killer cell activity in rheumatoid arthritis Clinical and Experimental Immunology 68(3): 535-542
Lynch, D.H.; Miller, R.E. 1990: Induction of murine lymphokine-activated killer cells by recombinant IL-7 Journal of Immunology 145(6): 1983-1990
Tani, M.; Tanimura, H.; Yamaue, H.; Tsunoda, T.; Iwahashi, M.; Noguchi, K.; Tamai, M.; Hotta, T.; Mizobata, S. 1993: Augmentation of lymphokine-activated killer cell activity by lentinan Anticancer Research 13(5c): 1773-1776
Hamada, F.; Fuchimoto, S.; Orita, K. 1989: Suppression of lymphokine activated killer (LAK) cells by immunosuppressive substance Research Communications in Chemical Pathology and Pharmacology 65(1): 81-95
Glassman, A.B. 1989: Interleukin-2 and lymphokine activated killer cells: promises and cautions Annals of Clinical and Laboratory Science 19(1): 51-55
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Nakano, E. 1992: Lymphokine-activated killer (LAK) therapy for metastatic renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1305-1309
Ballas, Z.K.; Rasmussen, W. 1990: Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations Journal of Immunology 144(1): 386-395
Ujházy, P.; Maccubbin, D.; Eppolito, C.; Mihich, E.; Ehrke, M.J. 1994: TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells Lymphokine and Cytokine Research 13(2): 99-106
Ballas, Z.K.; Rasmussen, W.; van Otegham, J.K. 1987: Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations Journal of Immunology 138(5): 1647-1652
Liu, C.C.; Walsh, C.M.; Eto, N.; Clark, W.R.; Young, J.D. 1995: Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells Journal of Immunology 155(2): 602-608
Chao, T.Y.; Hwang, W.S.; Yeh, M.Y. 1995: Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions Proceedings of the National Science Council Republic of China. Part B Life Sciences 19(2): 92-98
Montagna, D.; Maccario, R.; Ugazio, A.G.; Mingrat, G.; Burgio, G.R. 1988: Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity Clinical and Experimental Immunology 71(1): 177-181
Nii, A.; Sone, S.; Okubo, A.; Fawzy, F.; Yanagawa, H.; Ogura, T. 1987: Lymphokine-activated killer (LAK) adoptive immunotherapy: optimal method for large-scale LAK induction Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1871-1876
Segerson, E.C.; Gunsett, F.C. 1994: In vitro and in vivo effects of lymphokine-activated killer cells upon preattachment ovine conceptuses Journal of Immunology 152(6): 2938-2951
Blanchard, D.K.; Djeu, J.Y. 1988: Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma Journal of Immunology 141(11): 4067-4073